Skip to Content

barr 513 (Acetazolamide Extended Release 500 mg)

Pill imprint barr 513 has been identified as Acetazolamide extended release 500 mg.

Acetazolamide is used in the treatment of mountain sickness / altitude sickness; pseudotumor cerebri; edema; hydrocephalus; glaucoma (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Acetazolamide extended release 500 mg barr 513
Acetazolamide extended release 500 mg barr 513
Discount Card Promo
Acetazolamide extended release
barr 513
500 mg
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
sodium lauryl sulfate
magnesium silicate
D&C Red No. 28
D&C Yellow No. 10
FD&C Red No. 40
titanium dioxide
FD&C Blue No. 1
FD&C Blue No. 2
propylene glycol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.